Resumo

BELMAR VEGA, Lara et al. New oral anticoagulants in patients with chronic kidney disease. Nefrología (Madr.) [online]. 2017, vol.37, n.3, pp.244-252. ISSN 1989-2284.  https://dx.doi.org/10.1016/j.nefro.2016.08.006.

Patients with chronic kidney disease (CKD) develop bleeding and thrombotic tendencies, so the indication of anticoagulation at the onset of atrial fibrillation (AF) is complex. AF is the most common chronic cardiac arrhythmia, and thromboembolism and ischemic stroke in particular are major complications. In recent years, new oral anticoagulant drugs have been developed, and they have shown superiority over the classical AVK in preventing stroke, systemic embolism and bleeding risk, constituting an effective alternative to those resources.

Palavras-chave : Oral anticoagulants; Atrial fibrillation; Chronic kidney disease.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )